ClinConnect ClinConnect Logo
Search / Trial NCT00453674

German Adrenocortical Carcinoma Registry

Launched by UNIVERSITY OF WUERZBURG · Mar 28, 2007

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Adrenal Cancer Treatment Surgery Mitotane

ClinConnect Summary

The German Adrenocortical Carcinoma Registry is a clinical trial aimed at improving the care of patients with adrenocortical carcinoma, a rare type of cancer that affects the adrenal glands. The main goal of this registry is to gather information from as many patients as possible to better understand how different treatments work and to help design future studies. By collecting this data, researchers hope to create better treatment plans and improve the overall care for patients with this condition. The registry also collaborates with networks in other countries, such as Italy and France, to enhance therapy options on a larger scale.

If you or a loved one has been diagnosed with adrenocortical carcinoma, you may be eligible to participate in this registry. To join, participants must have a confirmed diagnosis of this type of cancer. Being part of this registry means that your health information will contribute to important research that could benefit current and future patients. While the trial is currently recruiting, it is open to all ages and genders. Participating in the registry does not require any specific treatment changes, but it gives you a chance to help improve cancer care for others.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Histologically confirmed diagnosis of adrenocortical carcinoma

About University Of Wuerzburg

The University of Würzburg, a prestigious institution located in Bavaria, Germany, is renowned for its commitment to advancing medical research and education. With a rich history dating back to 1402, the university is home to a diverse range of interdisciplinary research initiatives, particularly in the fields of medicine, life sciences, and pharmacology. As a clinical trial sponsor, the University of Würzburg is dedicated to conducting innovative research that aims to improve patient outcomes and contribute to the global medical community. The institution emphasizes ethical practices, rigorous scientific methodologies, and collaboration with various stakeholders to ensure the integrity and success of its clinical trials.

Locations

Wuerzburg, , Germany

Patients applied

0 patients applied

Trial Officials

Martin Fassnacht, MD

Principal Investigator

University of Wuerzburg

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials